Aleksander Kłósek
Managing Partner @ YouNick Mint
Poznan, Poland
Aleksander Kłósek is a seed investor at YouNick Mint in Poznan focused on Health Care and Food and Beverage. Aleksander Klósek - Managing Partner at YouNick Mint VC. Focused on seed and early-stage investments in healthcare & digital healthcare space. 15+ years of experience in pharmaceutical sales management and equity investment in healthcare, digital healthcare, pharma, food tech and industry 4.0. Led or participated in 30+ capital investments andexit transactions, including sale of 100% of shares of SmartPharma portfolio company to global pharmaceutical company. Passionate about working with entrepreneurs, scientists and medical experts to create unique value of the innovative tech companies for clients and investors. MS in Psychology and MBA graduate. Passionate traveler.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Aleksander Kłósek invests in
Stages Aleksander Kłósek invests in
Countries Aleksander Kłósek invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 1 (33%)
- Food and Beverage 1 (33%)
Stage
- Seed 2 (67%)
- Series A 1 (33%)
Country
- Poland 1 (33%)
- United Kingdom 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| SUPERSONIC is a brand of products that replace traditional meals and beverages (meal replacement product), are innovative in their recipe and consist of the best plant components.SUPERSONIC are products of plant origin created by scientists, nutritionists and biotechnologists, that provide full nutritional value, build immunity and delay theaging process. | $1.6M / Seed / Mar 15, 2023 | ||
| Prosoma was born out a need to provide more comprehensive care for cancer patients. We have found a fundamental lack of access to psychological care for patients who not only have to face a life-altering disease and treatment, but also crucially have a different set of needs than other psychological patients. Barriers to accessing psychologicalcare often include low numbers of therapists and clinicians in the area, financial or geographical limitations, and the general wellbeing of patients preventing them from attending meetings. All of these issues can be solved by modern technology.By using VR as part of, or when necessary, an alternative to traditional psychological treatment, we can reach patients that would otherwise be left without any support. They can use our tool at home or in the clinics whilst undergoing pharmacological treatment and chemotherapy.We hope to provide patients with a tool that will help them manage stress, cope with the burden of cancer, and eventually improve their quality of life. | $3.6M / Series A / Dec 19, 2022 | ||
| Prosoma was born out a need to provide more comprehensive care for cancer patients. We have found a fundamental lack of access to psychological care for patients who not only have to face a life-altering disease and treatment, but also crucially have a different set of needs than other psychological patients. Barriers to accessing psychologicalcare often include low numbers of therapists and clinicians in the area, financial or geographical limitations, and the general wellbeing of patients preventing them from attending meetings. All of these issues can be solved by modern technology.By using VR as part of, or when necessary, an alternative to traditional psychological treatment, we can reach patients that would otherwise be left without any support. They can use our tool at home or in the clinics whilst undergoing pharmacological treatment and chemotherapy.We hope to provide patients with a tool that will help them manage stress, cope with the burden of cancer, and eventually improve their quality of life. | $3.2M / Seed / Dec 19, 2022 |
Co-Investors
About YouNick Mint
YouNick Mint is an investment team managed by business practitioners working together for years in the areas of Healthcare (pharma, medical devices, innovative materials and medical devices) and Industry 4.0 (materials technology, ICT, RPA, PropTech). Younick has invested in nearly 50 innovative early-stage companies, he has invested in nearly 50companies through four investment vehicles, with several exits, including the sale of 100% of a portfolio company SmartPharma to a global pharmaceutical company. Under its current fund - Open Innovation by YouNick Mint, it invests jointly with private co-investors amounts of €1 to €2 million at 60%/40% parity. Partners of the YouNick team include private investors, business angels, as well as the National Research and Development Center and PFR Ventures.
YouNick Mint Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Aleksander Kłósek
Managing Partner
|
|||
|
Michał Janer
Researcher / Business Office Manager; Researcher / Business Office Manager
|
|||
Piotr Danielewicz
Investment Manager
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Aleksander Kłósek invest in?
Aleksander Kłósek invests primarily in Health Care and Food and Beverage startups, most often at Seed and Series A stage. Most of the 3 investments tracked by Shizune back companies in Poland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Aleksander Kłósek?
Public channels for Aleksander Kłósek include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Aleksander Kłósek last invest?
The most recent investment recorded for Aleksander Kłósek closed in Mar 2023. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
